# Use of Fidaxomicin Compared to Vancomycin for Decolonization of C. Difficile in Patients With Inflammatory Bowel Disease

> **NCT06794944** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Brigham and Women's Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Inflammatory Bowel Disease (IBD)
- Clostridioides Difficile Infection

## Interventions

- **DRUG:** Vancomycin (POC)
- **DRUG:** Fidaxomicin

## Key facts

- **NCT ID:** NCT06794944
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2030-09-01
- **Final completion:** 2031-09
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06794944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06794944, "Use of Fidaxomicin Compared to Vancomycin for Decolonization of C. Difficile in Patients With Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06794944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*